URGO

HUMAGRIP 16 TABLETS

Composition.

The active substances are:

Tablet: paracetamol 500 mg, pseudoephedrine hydrochloride 60 mg

Capsule: paracetamol 500 mg, chlorpheniramine maleate 4 mg.

The other ingredients are:

Tablet: microcrystalline cellulose, pregelatinized starch, croscarmellose sodium, magnesium stearate, povidone K 30.

Capsule: talc, sodium lauryl sulfate, anhydrous colloidal silicon dioxide, croscarmellose sodium, erythrosine (E127), indigotine (E132), titanium dioxide (E171), gelatin.

Therapeutic indications.

HUMAGRIP tablets and capsules are a nasal decongestant for systemic use, sympathomimetic, peripheral analgesic, antipyretic and antihistamine H1.

HUMAGRIP tablets and capsules are indicated for the short-term symptomatic treatment of flu conditions accompanied by headache and/or fever and a feeling of "stuffy nose".

It is recommended only for adults and children over 15 years of age. If you do not feel better or feel worse after 4 days, you should see a doctor.

Dosage and method of administration.

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Talk to your doctor or pharmacist if you are not sure.

The recommended dose is 1 white tablet in the morning and 1 blue-white capsule in the evening before bedtime; if necessary, another tablet can be taken at noon and one in the early evening. The maximum dose of 3 tablets and 1 capsule should not be exceeded. An interval of at least 4 hours should be observed between administrations. The interval increases to 8 hours in severe renal failure, but only on the doctor's recommendation.

The tablet or capsule should be swallowed with a large glass of water.

The maximum duration of treatment is 4 days.

Precautions.

Before taking HUMAGRIP tablets and capsules, talk to your doctor or pharmacist.

The absence of improvement or worsening of symptoms after 4 days of treatment, the appearance of an allergic reaction, tachycardia, palpitations, high blood pressure, arrhythmias, nausea or neurological signs require discontinuation of treatment and a medical check-up.

Paracetamol and its metabolites are excreted mainly in the urine and therefore, in severe renal failure, the interval between doses should be increased to 8 hours.

If other medicines are being taken, their paracetamol content should be checked to avoid overdose.

In adults and children weighing over 50 kg, the total daily dose of paracetamol should not exceed 3 g.

Special warnings.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

The presence of pseudoephedrine requires that HUMAGRIP should not be used during pregnancy. Experimental and clinical studies carried out on several hundred pregnant women have excluded the malformative effect of pseudoephedrine. Fetal toxicity is related to the pharmacological action of the molecule and can manifest as fetal tachycardia and hyperactivity.

Consequently, pseudoephedrine may only be prescribed during pregnancy if absolutely necessary and only on the doctor's recommendation. It is contraindicated when there is fetal distress or hypertensive maternal pathology.

HUMAGRIP is contraindicated during breastfeeding because pseudoephedrine is excreted in breast milk and can cause tachycardia in the infant.

Driving and using machines

Drivers and people operating machinery should be warned that HUMAGRIP can cause drowsiness or mild agitation.

Packaging. Box with a PVC/Al blister of 12 tablets and 4 capsules.

 

Page updated on: 25.08.2022